Carlo Zanon

Carlo Zanon

UNVERIFIED PROFILE

Are you Carlo Zanon?   Register this Author

Register author
Carlo Zanon

Carlo Zanon

Publications by authors named "Carlo Zanon"

Are you Carlo Zanon?   Register this Author

32Publications

1235Reads

15Profile Views

Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia.

Pediatr Blood Cancer 2020 Jan 1;67(1):e28025. Epub 2019 Oct 1.

Department of Woman's and Child's Health, University-Hospital of Padua, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28025DOI Listing
January 2020

miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma.

J Clin Pathol 2018 Apr 4;71(4):344-350. Epub 2017 Sep 4.

Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2017-204690DOI Listing
April 2018

TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy.

Eur J Pharmacol 2018 Jan 14;818:435-448. Epub 2017 Nov 14.

Pediatric Research Institute - Città della Speranza, Neuroblastoma Laboratory, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2017.11.016DOI Listing
January 2018

Transcription instability in high-risk neuroblastoma is associated with a global perturbation of chromatin domains.

Mol Oncol 2017 11 10;11(11):1646-1658. Epub 2017 Oct 10.

Neuroblastoma Laboratory, Pediatric Research Institute, Citta' della Speranza, Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1878-0261.12139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664000PMC
November 2017

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone.

Neuro Oncol 2014 Sep 6;16(9):1263-73. Epub 2014 Feb 6.

Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (R.J.M., C.J.F.v.N.); Neurosurgical Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands (F.E.B., D.V., W.P.V.); Laboratory of Molecular Genetics, The Oncogenomics Center, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo, Italy (S.La., C.Z., A.B., F.E.B.); Department of Pathology, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands (J.W.M.J., S.H.E.B.-S., P.W.); Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands (P.W.); Department of Neurogenetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (T.J.M.H.); Department of Neuropathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands (D.T., A.A.v.T.); Neurosurgical Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands (W.P.V.); Department of Neurosurgery, St. Elisabeth Hospital Tilburg, The Netherlands (S.Le.); Department of Neurosurgery, Erasmus Medical Center, Rotterdam, The Netherlands (S.Le.); FIRC Institute of Molecular Oncology, Milan, Italy (A.B.)Present affiliation: Department of Clinical Genetics, Academic Medical Center and University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands (F.E.B.); Department of Pathology, Radboud University Medical Center Nijmegen, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands (A.A.v.T.); Department of Neurology, Radboud University Medical Centre Nijmegen, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands (S.H.E.B.-S.); Department of Pathology, Stichting PAMM, Michelangelolaan 2, 5623 EJ Eindhoven, The Netherlands (J.W.M.J.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/nou005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136888PMC
September 2014

Mutational profiling of kinases in glioblastoma.

BMC Cancer 2014 Sep 26;14:718. Epub 2014 Sep 26.

Department of Oncology, University of Torino, SP 142, Km 3,95, Candiolo, Torino, 10060, Italy; Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192443PMC
September 2014

European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene.

Hum Mol Genet 2011 Nov 12;20(21):4268-81. Epub 2011 Jul 12.

deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddr303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188988PMC
November 2011

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.

Nat Genet 2010 May 28;42(5):415-9. Epub 2010 Mar 28.

Department of Epidemiology, Biostatistics and Health Technology Assessment, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2923020PMC
May 2010

Absence of AKT1 mutations in glioblastoma.

PLoS One 2009 May 20;4(5):e5638. Epub 2009 May 20.

Neurosurgical Center Amsterdam, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005638PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680963PMC
May 2009

PIK3CA cancer mutations display gender and tissue specificity patterns.

Hum Mutat 2008 Feb;29(2):284-8

Laboratory of Molecular Genetics, The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, Candiolo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.20648DOI Listing
February 2008

Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.

Cancer Res 2007 Apr;67(8):3545-50

Laboratory of Molecular Genetics, The Oncogenomics Center, Institute for Cancer Research and Treatment, University of Torino Medical School, Candiolo (TO) 10060, Italy.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-07-0065DOI Listing
April 2007